Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Regression of cervical spinal cord compression in a patient with chordoma following treatment with cetuximab and gefitinib.

× No keyword cloud information.

21 in total

1. A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity employing NK or high-affinity NK cells in combination with cetuximab.

Authors: Rika Fujii; Jeffrey Schlom; James W Hodge
Journal: J Neurosurg Date: 2017-07-28 Impact factor: 5.115

2. Prognostic significance of immunohistochemical expression of VEGFR2 and iNOS in spinal chordoma.

Authors: Reza Akhavan-Sigari; Michael Robert Gaab; Veit Rohde; Mehdi Abili; Helmut Ostertag
Journal: Eur Spine J Date: 2014-06-15 Impact factor: 3.134

Review 3. Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review.

Authors: Simon G Launay; Bruno Chetaille; Fanny Medina; Delphine Perrot; Serge Nazarian; Jérôme Guiramand; Laurence Moureau-Zabotto; François Bertucci
Journal: BMC Cancer Date: 2011-10-04 Impact factor: 4.430

Review 4. Systemic therapy options for unresectable and metastatic chordomas.

Authors: Silvia Stacchiotti; Paolo Giovanni Casali
Journal: Curr Oncol Rep Date: 2011-08 Impact factor: 5.075

Review 5. The biological basis for modern treatment of chordoma.

Authors: Roberto Jose Diaz; Michael D Cusimano
Journal: J Neurooncol Date: 2011-03-08 Impact factor: 4.130

6. Immunohistochemical expression of receptor tyrosine kinase PDGFR-α, c-Met, and EGFR in skull base chordoma.

Authors: R Akhavan-Sigari; M Abili; M R Gaab; V Rohde; N Zafar; P Emami; H Ostertag
Journal: Neurosurg Rev Date: 2014-10-17 Impact factor: 3.042

7. Multidisciplinary management of recurrent chordomas.

Authors: Yoshiya Yamada; Mrinal Gounder; Ilya Laufer
Journal: Curr Treat Options Oncol Date: 2013-09

Review 8. Targeted therapies: the rare cancer paradigm.

Authors: Marco A Pierotti; Tiziana Negri; Elena Tamborini; Federica Perrone; Sabrina Pricl; Silvana Pilotti
Journal: Mol Oncol Date: 2009-10-28 Impact factor: 6.603

9. Prognostic value of MIB-1, p53, epidermal growth factor receptor, and INI1 in childhood chordomas.

Authors: Rajni Yadav; Mehar Chand Sharma; Prit Benny Malgulwar; Pankaj Pathak; Elanthenral Sigamani; Vaishali Suri; Chitra Sarkar; Amandeep Kumar; Manmohan Singh; Bhawani Shankar Sharma; Ajay Garg; Sameer Bakhshi; Mohammed Faruq
Journal: Neuro Oncol Date: 2013-12-04 Impact factor: 12.300

10. Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas.

Authors: Elena Tamborini; Emanuela Virdis; Tiziana Negri; Marta Orsenigo; Silvia Brich; Elena Conca; Alessandro Gronchi; Silvia Stacchiotti; Giacomo Manenti; Paolo G Casali; Marco A Pierotti; Silvana Pilotti
Journal: Neuro Oncol Date: 2010-02-17 Impact factor: 12.300